---
title: "60 Degrees Pharmaceuticals files updated legal opinion confirming ATM program share validity"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/279094792.md"
description: "60 Degrees Pharmaceuticals has filed an updated legal opinion confirming the validity of shares issued under its at-the-market equity offering program. This opinion relates to shares sold under the ATM Program as per the Sales Agreement with HC Wainwright dated September 5, 2025. It confirms the validity of the shares and addresses certain legal matters without altering the terms of the ATM Program. The full opinion text is available as Exhibit 5.1 in the original SEC filing."
datetime: "2026-03-13T21:23:00.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/279094792.md)
  - [en](https://longbridge.com/en/news/279094792.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/279094792.md)
---

# 60 Degrees Pharmaceuticals files updated legal opinion confirming ATM program share validity

**60 Degrees Pharmaceuticals filed an updated legal opinion confirming the validity of shares issued under its at-the-market equity offering program.**

**Key Highlights:**

-   Updated counsel opinion related to shares sold under the ATM Program pursuant to Sept. 5, 2025 Sales Agreement with HC Wainwright.
-   Opinion confirms validity of shares and addresses certain legal matters under applicable law, without changing ATM Program terms.
-   Full opinion text is filed as Exhibit 5.1 and the summary is qualified by that complete document.

Original SEC Filing: 60 DEGREES PHARMACEUTICALS, INC. \[ SXTP \] - 8-K - Mar. 13, 2026

**Disclaimer**

This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.

### Related Stocks

- [VHT.US](https://longbridge.com/en/quote/VHT.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [ARKG.US](https://longbridge.com/en/quote/ARKG.US.md)
- [SXTPW.US](https://longbridge.com/en/quote/SXTPW.US.md)
- [XLV.US](https://longbridge.com/en/quote/XLV.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [IHE.US](https://longbridge.com/en/quote/IHE.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [IXJ.US](https://longbridge.com/en/quote/IXJ.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [SXTP.US](https://longbridge.com/en/quote/SXTP.US.md)

## Related News & Research

- [Pfizer AGM: Shareholders Reject Independent Chair Proposal as Bourla Touts 2025 Gains and Pipeline](https://longbridge.com/en/news/284154965.md)
- [Caris Life Sciences Publishes Study Validating Caris AI Insights for Temozolomide Benefit in Glioblastoma Patients | CAI Stock News](https://longbridge.com/en/news/284572256.md)
- [Equities Analysts Offer Predictions for NRXP Q1 Earnings](https://longbridge.com/en/news/284367413.md)
- [Erasca publishes corporate presentation on RAS/MAPK cancer drug pipeline](https://longbridge.com/en/news/284792355.md)
- [Sagimet Highlights Pipeline Progress and Strategic Corporate Developments](https://longbridge.com/en/news/284209078.md)